Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 111

    1.

    Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.

    Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, Wright EC, Brunt EM, Kleiner DE, Shiffman ML, Everson GT, Lindsay KL, Dienstag JL, Morishima C; HALT-C Trial Group.

    Hepatology. 2009 Dec;50(6):1738-49.PMID: 19824074 [PubMed - in process]Related articles

    2.

    Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C.

    Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL; HALT-C Trial Group.

    Gastroenterology. 2009 Sep 18. [Epub ahead of print]PMID: 19766643 [PubMed - as supplied by publisher]Related articles

    3.

    Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.

    Hall LJ, Clare S, Pickard D, Clark SO, Kelly DL, El Ghany MA, Hale C, Dietrich J, Andersen P, Marsh PD, Dougan G.

    Vaccine. 2009 Nov 16;27(49):6894-904. Epub 2009 Sep 13.PMID: 19755145 [PubMed - in process]Related articles

    4.

    Effect of HCV RNA suppression during peginterferon Alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.

    Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

    Gastroenterology. 2009 Dec;137(6):1986-94. Epub 2009 Sep 10.PMID: 19747918 [PubMed - in process]Related articles

    5.

    Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner.

    Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B.

    Gastroenterology. 2009 Sep 10. [Epub ahead of print]PMID: 19747917 [PubMed - as supplied by publisher]Related articles

    6.

    Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

    Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group.

    Hepatology. 2009 Nov;50(5):1360-9.PMID: 19676128 [PubMed - in process]Related articles

    7.

    Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma.

    Henderson WA, Shankar R, Gill JM, Kim KH, Ghany MG, Skanderson M, Butt AA.

    J Viral Hepat. 2009 Jun 28. [Epub ahead of print]PMID: 19566787 [PubMed - as supplied by publisher]Related articles

    8.

    Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.

    Kottilil S, Yan MY, Reitano KN, Zhang X, Lempicki R, Roby G, Daucher M, Yang J, Cortez KJ, Ghany M, Polis MA, Fauci AS.

    Hepatology. 2009 Jul;50(1):34-45.PMID: 19551908 [PubMed - indexed for MEDLINE]Related articles

    9.

    Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

    Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

    Gastroenterology. 2009 Aug;137(2):549-57. Epub 2009 May 13.PMID: 19445938 [PubMed - indexed for MEDLINE]Related articles

    10.

    Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

    Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR; HALT-C Trial Group.

    Hepatology. 2009 Jun;49(6):1847-58.PMID: 19434718 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antiviral resistance and hepatitis B therapy.

    Ghany MG, Doo EC.

    Hepatology. 2009 May;49(5 Suppl):S174-84.PMID: 19399794 [PubMed - indexed for MEDLINE]Related articles

    12.

    Diagnosis, management, and treatment of hepatitis C: an update.

    Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases.

    Hepatology. 2009 Apr;49(4):1335-74. No abstract available. PMID: 19330875 [PubMed - indexed for MEDLINE]Related articles

    13.

    Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.

    Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C; HALT-C Trial Group.

    Hepatology. 2009 Jun;49(6):1828-37.PMID: 19291787 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

    Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

    N Engl J Med. 2008 Dec 4;359(23):2429-41.PMID: 19052125 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

    Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

    Gastroenterology. 2009 Jan;136(1):138-48. Epub 2008 Sep 18.PMID: 18848939 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.

    Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM; HALT-C Trial Group.

    Hepatology. 2008 Nov;48(5):1412-9.PMID: 18816437 [PubMed - indexed for MEDLINE]Related articles

    17.

    DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.

    Morgan TR, Lambrecht RW, Bonkovsky HL, Chung RT, Naishadham D, Sterling RK, Fontana RJ, Lee WM, Ghany MG, Wright EC, O'Brien TR; HALT-C Trial Group.

    J Hepatol. 2008 Oct;49(4):548-56. Epub 2008 Jun 5.PMID: 18619701 [PubMed - indexed for MEDLINE]Related articles

    18.

    Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.

    Lindsay KL, Morishima C, Wright EC, Dienstag JL, Shiffman ML, Everson GT, Lok AS, Bonkovsky HL, Lee WM, Morgan TR, Ghany MG; HALT-C Trial.

    Clin Gastroenterol Hepatol. 2008 Feb;6(2):234-41.PMID: 18237873 [PubMed - indexed for MEDLINE]Related articles

    19.

    Association between body mass index and diabetes and hepatocellular carcinoma.

    Loomba R, Ghany M.

    Ann Intern Med. 2008 Jan 15;148(2):166-7; author reply 167. No abstract available. PMID: 18195343 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

    Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group.

    Hepatology. 2008 Feb;47(2):605-12.PMID: 18157835 [PubMed - indexed for MEDLINE]Related articles

    21.

    The effect of different mandibular dentures on antagonistic maxillary ridge.

    Abd El-Dayem MA, Assad AS, Abdel-Ghany MM.

    Implant Dent. 2007 Dec;16(4):421-9.PMID: 18091171 [PubMed - indexed for MEDLINE]Related articles

    22.

    Evolution of therapy for chronic hepatitis B: progressing from the simple to the complex.

    Feld JJ, Ghany MG.

    Ann Intern Med. 2007 Dec 4;147(11):806-8. No abstract available. PMID: 18056667 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Two cases of thyroid storm-associated cholestatic jaundice.

    Hull K, Horenstein R, Naglieri R, Munir K, Ghany M, Celi FS.

    Endocr Pract. 2007 Sep;13(5):476-80.PMID: 17872349 [PubMed - indexed for MEDLINE]Related articles

    24.

    Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

    Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, Ghany MG, Pawlotsky JM, Liaw YF, Mizokami M, Kuiken C; Hepatitis B Virus Drug Resistance Working Group.

    Hepatology. 2007 Jul;46(1):254-65. Review.PMID: 17596850 [PubMed - indexed for MEDLINE]Related articles

    25.

    The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.

    Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, Borg B, Loomba R, Liang TJ, Premkumar A, Hoofnagle JH.

    Hepatology. 2007 Aug;46(2):424-9.PMID: 17559148 [PubMed - indexed for MEDLINE]Related articles

    26.

    Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus.

    Yee LJ, Tang YM, Kleiner DE, Wang D, Im K, Wahed A, Tong X, Rhodes S, Su X, Whelan RM, Fontana RJ, Ghany MG, Borg B, Liang TJ, Yang H; Virahep-C Study Group.

    Hepatology. 2007 Jul;46(1):74-83.PMID: 17526009 [PubMed - indexed for MEDLINE]Related articles

    27.

    Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy.

    Lutchman G, Danehower S, Song BC, Liang TJ, Hoofnagle JH, Thomson M, Ghany MG.

    Gastroenterology. 2007 May;132(5):1757-66. Epub 2007 Mar 24.PMID: 17484873 [PubMed - indexed for MEDLINE]Related articles

    28.

    Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B.

    Ghany M, Liang TJ.

    Gastroenterology. 2007 Apr;132(4):1574-85. Review.PMID: 17408658 [PubMed - indexed for MEDLINE]Related articles

    29.

    Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.

    Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML, Everson GT, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Ghany MG, Morishima C; HALT-C Trial Group.

    Clin Gastroenterol Hepatol. 2007 Feb;5(2):245-54.PMID: 17296533 [PubMed - indexed for MEDLINE]Related articles

    30.

    Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.

    Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR.

    Gastroenterology. 2007 Jan;132(1):103-12. Epub 2006 Nov 11.PMID: 17241864 [PubMed - indexed for MEDLINE]Related articles

    31.

    Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

    Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group.

    J Hepatol. 2007 Mar;46(3):420-31. Epub 2006 Nov 27.PMID: 17196293 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.

    Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan JA, Malet PF, Mehta S, Sheikh MY, Reid AE, Ghany MG, Gretch DR, Halt-C Trial Group.

    Gastrointest Endosc. 2006 Dec;64(6):855-64.PMID: 17140886 [PubMed - indexed for MEDLINE]Related articles

    33.

    Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

    Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C; HALT-C Trial Group.

    Hepatology. 2006 Dec;44(6):1675-84.PMID: 17133499 [PubMed - indexed for MEDLINE]Related articles

    34.

    Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.

    Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C; HALT-C Trial Group.

    Gastroenterology. 2006 Nov;131(5):1440-51. Epub 2006 Aug 18.PMID: 17101320 [PubMed - indexed for MEDLINE]Related articles

    35.

    Efforts to define the natural history of chronic hepatitis C continue.

    Ghany MG, Seeff LB.

    Clin Gastroenterol Hepatol. 2006 Oct;4(10):1190-2. No abstract available. PMID: 17045209 [PubMed - indexed for MEDLINE]Related articles

    36.

    Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.

    Fontana RJ, Kleiner DE, Bilonick R, Terrault N, Afdhal N, Belle SH, Jeffers LJ, Ramcharran D, Ghany MG, Hoofnagle JH; Virahep-C Study Group.

    Hepatology. 2006 Oct;44(4):925-35.PMID: 17006909 [PubMed - indexed for MEDLINE]Related articles

    37.

    HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.

    Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group.

    Hepatology. 2006 Aug;44(2):360-7.PMID: 16871570 [PubMed - indexed for MEDLINE]Related articles

    38.

    Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement.

    Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, Liang TJ, Hoofnagle JH.

    Clin Gastroenterol Hepatol. 2006 Aug;4(8):1048-52. Epub 2006 Jun 30.PMID: 16814613 [PubMed - indexed for MEDLINE]Related articles

    39.

    Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.

    Fontana RJ, Sanyal AJ, Mehta S, Doherty MC, Neuschwander-Tetri BA, Everson GT, Kahn JA, Malet PF, Sheikh MY, Chung RT, Ghany MG, Gretch DR; HALT-C Trial Group.

    Am J Gastroenterol. 2006 May;101(5):983-92.PMID: 16573786 [PubMed - indexed for MEDLINE]Related articles

    40.

    Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.

    Perumalswami P, Kleiner DE, Lutchman G, Heller T, Borg B, Park Y, Liang TJ, Hoofnagle JH, Ghany MG.

    Hepatology. 2006 Apr;43(4):780-7.PMID: 16557550 [PubMed - indexed for MEDLINE]Related articles

    41.

    Assessment and management of chronic hepatitis B.

    Ghany MG, Doo EC.

    Infect Dis Clin North Am. 2006 Mar;20(1):63-79.PMID: 16527649 [PubMed]Related articles

    42.

    Assessment of liver fibrosis: palpate, poke or pulse?

    Ghany MG, Doo E.

    Hepatology. 2005 Oct;42(4):759-61. Review. No abstract available. PMID: 16175617 [PubMed - indexed for MEDLINE]Related articles

    43.

    Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

    Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR; HALT-C Trial Group.

    J Hepatol. 2005 Sep;43(3):434-41.PMID: 16136646 [PubMed - indexed for MEDLINE]Related articles

    44.

    Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

    Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C.

    Hepatology. 2005 Aug;42(2):282-92.PMID: 15986415 [PubMed - indexed for MEDLINE]Related articles

    45.

    Pilot study of interferon gamma for chronic hepatitis C.

    Soza A, Heller T, Ghany M, Lutchman G, Jake Liang T, Germain J, Hsu HH, Park Y, Hoofnagle JH.

    J Hepatol. 2005 Jul;43(1):67-71. Epub 2005 Apr 26.PMID: 15913831 [PubMed - indexed for MEDLINE]Related articles

    46.

    Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.

    Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE, Gorden P.

    Hepatology. 2005 Apr;41(4):753-60.PMID: 15791619 [PubMed - indexed for MEDLINE]Related articles

    47.

    Pushing the treatment envelope for chronic hepatitis C--is more necessarily better?

    Lutchman G, Ghany M.

    Hepatology. 2005 Feb;41(2):234-6. Review. No abstract available. PMID: 15657958 [PubMed - indexed for MEDLINE]Related articles

    48.

    Cellular immune responses to the hepatitis B virus polymerase.

    Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, Rehermann B.

    J Immunol. 2004 Nov 1;173(9):5863-71.PMID: 15494540 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

    Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE; HALT-C Trial Group.

    Control Clin Trials. 2004 Oct;25(5):472-92.PMID: 15465617 [PubMed - indexed for MEDLINE]Related articles

    50.

    Management of chronic hepatitis B.

    Ghany MG, Doo EC.

    Gastroenterol Clin North Am. 2004 Sep;33(3):563-79, ix. Review.PMID: 15324944 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...